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FSHR is an important gene which plays a major role in the development of secondary sex characteristics and 
influences the female reproductive cycle by regulating the Follicle Stimulating Hormone. Though this gene and  
its protein are extensively studied, no attempts have been made yet to methodically analyze the variants in this gene.  
One of the chief objectives during the analysis of human genetic variation is to distinguish between the  
Single Nucleotide Polymorphisms (SNPs) that are functionally neutral from those that contribute to the disorder.  
To predict the possible impact of SNPs on the FSHR structure and function, data were obtained from NCBI (dbSNP  
and dbVar) and validated manually. Various bioinformatics tools were used to predict the alterations at transcriptional, 
post transcriptional stages and protein interaction. Around 38 variants reported by NCBI Variation Viewer were  
sorted by SIFT and 14 of them were reported damaging, 13 were reported to be either benign or damaging by  
PROVEAN and Panther. From these 13 SNPs, the most damaging (11 SNPs) were modeled using Pymol and the  
energy difference between the native and mutated structure was calculated by Swiss PDB – Viewer. Based on  
our analysis, we have reported potential candidate SNPs for the FSHR gene involved in the regulation of ovarian 
pathophysiology.  
Keywords: Computational analysis, Follicle stimulating hormone receptor (FSHR), Ovarian regulation, Single nucleotide 
polymorphism (SNPs)  
Follicle-Stimulating Hormone (FSH) is elemental for 
normal gametogenesis in humans and mammals
1-3
.  
In humans, FSH is vital for ovarian development  
and follicle maturation in females
2
 whereas,  
FSH determines Sertoli cell number and is  
required for quantitatively and qualitatively normal 
spermatogenesis in males
3
. FSH action is mediated 
by a G-protein coupled receptor–FSHR, which is 
exclusively expressed on granulosa and Sertoli 
cells
4
. Follicle Stimulating Hormone Receptor 
(FSHR) is a single-copy gene that has been mapped 
to the region 2p21-2p16 and spans a region of 54 kb. 
It consists of ten exons; the first nine exons encode 
for the large extracellular domain and the trans 
membrane domain is comprised of the tenth exon
5
. 
Some structural changes occurring in the ―sensitive‖ 
portions of the gene may give rise to variations  
in the amino acid sequence of the protein. This  
will affect the receptor‘s functional properties  
that may be amplifying (activating mutations) or 
diminishing (inactivating mutations) and have 
clinical consequences
6
. 
Single nucleotide polymorphisms (SNPs) are  
very significant and also a common form of  
genetic variation in the genome. Though many  
SNPs have no particular effect on the functionality  
of the cell and tend to be neutral, some of them  
are accountable for different reasons that lead to 
genetic variations affirmative of various diseases
7
. 
Therefore, they can be of use as biological markers 
for finding out the disease vulnerability
8
. SNPs tend 
to manifest approximately every 1000 to 2000 bases. 
A non-synonymous SNP (nsSNP) is a variation in a 
single base that occurs in the coding area which 
accounts for a change in an amino acid of the protein 
that it encodes. As a consequence of nsSNP protein, 
functionality alters and the changes in them can result 
in a phenotypic effect that turns out to be an apparent 
reason for the pathology of a disorder
9
. Variants 
which can possibly result in a premature stop were 
likely to be in association with diseases at about a 
probability of 2.77%
10
. 
—————— 
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In silico prediction tools were used to efficiently 
filter out deleterious SNPs from the available data on 
the variants. It helps us in prioritizing SNPs of  
any functional significance thus narrowing the 
investigation of the disease-causing mutations  
which can contribute to disease susceptibility. 
Bioinformatics protein prediction tools can be  
used for finding out the structure and the  
structural variations that might occur due to  
the occurrence of SNPs. Here, we have attempted  
to predict the possible structural conformation  
of FSHR protein, identification of damaging  
variants and to find out possible changes that can 
occur in the protein. 
 
Materials and Methods 
Database of SNPs 
The detailed information of the FSHR gene was 
obtained from Online Mendelian Inheritance in  
Man (OMIM) and Entrez Gene on National Centre  
for Biological Information (NCBI) websites. The 
database of NCBI for SNPs (dbSNP) found  
at https://www.ncbi.nlm.nih.gov/snp was used  
to retrieve SNP information such as rs ID,  
functional class, variation class, clinical significance 
and its allele frequency. Entrez Gene accessed  
at http://grch37.ensembl.org/index.html gives the 
information on chromosome location and coordinates 
in base pairs, consequence type and amino  
acid coordinates. The list of rs IDs for further 
downstream analysis was obtained from NCBI‘s 
Variation Viewer (https://www.ncbi.nlm.nih.gov/ 
variation/view/), since this table gives varied options 
for classification.  
The particulars on the FSHR protein was obtained 
from Uniprot Knowledgebase accessed from 
http://www.uniprot.org/
11
. The mRNA accession 
number (NM_000145 and NM_181446) and the 
protein accession number (NP_000136 and 
NP_852111) of both the variants were retrieved. The 
native 3D structure and FASTA sequence for mutation 
modeling was obtained from Protein Data Bank (PDB) 
accessed at http://www.rcsb.org/pdb/ home/home.do
12
.  
 
Functional analysis prediction of non-synonymous SNPs 
Functional effect of non-synonymous SNPs 
obtained from Entrez Gene was predicted using  
various in silico algorithms. The nsSNPs predicted to 
be damaging were characterized to be of high-risk 
nsSNPs and they were used for predictive studies.  
The tools used for characterizing the damaging  
effects are SIFT, PolyPhen-2, PROVEAN, SNP & GO 
and PANTHER.  
Sorting Intolerant From Tolerant (SIFT) 
(http://sift.jcvi.org/) was used to observe the effect of 
amino acid (a.a.) substitution on protein function
13
. 
SIFT predicts the deleterious effect of nsSNPs by 
using algorithms that align closely related sequences 
using PSI-BLAST and predicts the damage using the 
degree of conservation of sequences. PolyPhen-2 
(http://genetics.bwh.harward.edu/pp2) is the shortened 
form of polymorphism phenotyping version 2
14
.  
We used PolyPhen to understand the probable impact 
of an amino acid substitution on structural and 
functional properties of the protein by taking  
in to account physical and comparative approaches. 
Protein Variation Effect Analyzer (PROVEAN) 
(http://provean.jcvi.org/index.php) tool was used for 
predicting if an amino acid substitution has an effect 
on protein‘s biological function and on further 
filtering sequence variants to find out nonsynonymous 
variants
15
. PROVEAN tool helps us to gather  
pair-wise sequence alignment scores and enables us to 
generate pre-computed predictions. Protein Analysis 
Through Evolutionary Relationships (PANTHER) 
(http://www.pantherdb.org/tools/ csnpScoreForm.jsp) 
was used to predict the damaging effect of  
nsSNPs
16
. PANTHER calculates the substitution 
position-specific evolutionary preservation (sub-PSEP) 
score, to predict the a.a. substitution that will  
cause any functional effect using Hidden Markov 
Model (HMM)
17
.  
 
Predicting effect of mutation on protein stability 
I-Mutant 2.0 (http://folding.uib.es/i-mutant/i-
mutant2.0.html), a neural network based tool, predicts 
the variations in the stability of the protein upon 
mutation
18
. This tool automatically predicts protein 
stability changes upon single site mutations. 
Prediction can be done using a protein structure or 
sequence from databases. The FASTA sequence of 
the protein from PDB with the accession number 
4AY9 was retrieved to predict the mutational effect 
on protein stability. The output obtained is in the form 
of the protein stability change upon mutation and 
Gibbs-free energy change (∆∆G). 
Also, the energy changes caused by the deleterious 
SNPs on the stability of a protein were checked by 
using Pymol and Swiss PDB
11
. When the energy of a 
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mutated protein was lesser than that of the native 
protein the respective SNP was considered to have a 
deleterious effect on the function of the protein.  
 
Prediction of Post-translational modification sites in FSHR  
Glycation sites of ε amino groups of lysine  
residues were predicted using a NetGlycate 1.0  
server (http://www.cbs.dtu.dk/services/NetGlycate/). 
In NetGlycate a score of >0.5 was considered 
glycated
19
. Phosphorylation sites were predicted using 
a NetPhos2.0 server (http://www.cbs.dtu.dk/ 
services/NetPhos/). In NetPhos2.0, serine, threonine 
and tyrosine residues with a score of >0.5 were 
considered to be phosphorylated
20
. Ubiquitylation 
sites were predicted using UbPred (www.ubpred.org). 
In Ubpred, lysine residues with a score of ≥0.62  
were considered ubiquitylated. Sumoylation  
sites were predicted using SUMO-plot (http:// 
www.abgent.com/sumoplot). For SUMO-plot high 
probability motifs having a score of 0.5 were 
considered sumoylated
21
. 
 
Predictions of protein-protein interactions 
STRING is a database that consists of detected  
and predicted protein-protein interactions
22
.  
The interactions include direct physical and  
indirect functional associations. The data develops 
from computationally predicted interactions, 
experimentally predicted interactions, knowledge 
transfer between organisms and information derived 
from other databases. This database was used to 
predict possible interactions of FSHR with other 
proteins. 
Results 
SNP dataset from dbSNP 
The dbSNP database contains both validated  
and non-validated polymorphisms but it is the  
most extensive database. The allelic frequency of 
most of the nsSNPs of INSR has been recorded here 
and it was validated by manual curation. Totally 
29117 SNPs were present in the FSHR gene for Homo 
sapiens as accessed on 24
th
 August 2017. When these 
SNPs were classified according to their multiple allele 
frequencies and given a heterozygosity score of  
40-50, only 795 SNPs were remaining. Then the list 
of rs IDs remaining was validated using dbSNP-Q and 
it reported 357 validated SNPs
23
. Also, the list of 
SNPs obtained from Entrez gene was merged with 
this list and the duplicates were removed. The 
remaining list of SNPs was used for input. 
The 795 variants can be classified based on the 
variation type as 126 indels and 669 single nucleotide 
polymorphisms. Among the 669 SNPs, 26 belonged 
to the functional class 3UTR, 7 SNPs were in 5UTR, 
and 633 were in the intronic region. On the whole 
(SNPs and Indels), the mutations can be classified 
according to their function as 32-3UTRs, 7- 5UTRs, 
736- introns, and 6-missense mutations. 
 
Functional effects of nsSNPs on FSHR as predicted by 
different tools 
SIFT characterizes the effect of amino acid 
substitution on protein function by using sequence 
homology. From SIFT results (Table 1), a total of  
9 nsSNPs were predicted as damaging (score of  
Table 1 — Functional Effects of nsSNPs as predicted by in silico tools 
SNP Amino acid change SIFT PROVEAN POLYPHEN2 PANTHER 
rs6166 S680N TOLERATED  benign  
rs121909660 R573C DAMAGING Deleterious probably damaging probably damaging 
rs28928871 D567N DAMAGING Deleterious probably damaging probably damaging 
rs121909664 I545T DAMAGING Deleterious probably damaging probably damaging 
rs121909662 P519T DAMAGING Deleterious probably damaging probably damaging 
rs28928870 T449I DAMAGING Deleterious probably damaging probably damaging 
rs121909663 T449A DAMAGING Deleterious probably damaging probably damaging 
rs121909661 A419T DAMAGING Deleterious probably damaging probably damaging 
rs6165 A307T TOLERATED Neutral benign probably begign 
rs121909658 A189V DAMAGING Deleterious probably damaging probably damaging 
rs111883853 R162K TOLERATED Neutral benign probably damaging 
rs121909659 I160T DAMAGING Deleterious benign probably begign 
rs121909665 S128Y TOLERATED Neutral probably damaging probably damaging 
rs115030945 L8F TOLERATED Neutral benign probably damaging 
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0.00-0.04) by SIFT and 5 nsSNPs were simulated to 
be tolerated (score of 0.08-0.55). The rest had no 
records found.  
PROVEAN calculates the effects of the variants on 
the respective biological function of the protein based 
on sequence homology. This algorithm functions 
mainly based on the primary sequence for prediction 
and other tools perform a similar task with the 
structure. PROVEAN has the advantage over other 
tools that it can predict a large number of substitutions 
and does not require structures. The scores of 
PROVEAN are classified as ―deleterious‖ below a 
certain upper limit (here −2.5) and ―neutral‖ above it. 
The list of SNPs was submitted manually to the 
―dbSNP rsIDs‖ page to calculate the PROVEAN 
score. The 9 SNPs claimed to be damaging by SIFT 
was also predicted as deleterious by PROVEAN and 
the 5 tolerated SNPs was predicted to be neutral 
(Table 1). Among the 9 deleterious nsSNPs 
mutations, R573C and P519T were predicted as 
highly deleterious with PROVEAN scores of −6.55 
and −6.97, respectively. 
PolyPhen estimates the difference between the 
variant scores using the algorithm where the 
homologues of the input sequences are identified via 
BLAST and PSIC scores are calculated for every 
variant and the difference of 0.339 is accepted as 
detrimental. The protein accession number of FSHR 
(NP_000136) and the amino acid change in each 
position, corresponding to each of the 14 nsSNPs 
(output of SIFT) were submitted as a batch query. 
Table 3 encapsulates the results obtained from the 
PolyPhen server. A PSIC score difference was 
allocated to categorize SNPs as benign and damaging. 
―PolyPhen-2: scores are assigned as 0.000 (most 
probably benign) to 0.999 (most probably 
damaging).‖ Nine of the 14 nsSNPs were predicted as 
―damaging‖. These nsSNPs were also predicted to be 
deleterious by the SIFT. 
Protein ANalysis THrough Evolutionary 
Relationships (PANTHER) characterizes probable 
functional consequence of amino acid variation by 
means of HMM-based statistical modelling and  
also family multiple sequence alignments and 
phylogenetic trees. PANTHER analysis of FSHR 
nsSNPs was executed in order to add another layer  
of refinement in SNPs characterization. PSEP  
score was used to categorise the variants and  
it measures in million years (my). The longer an 
amino acid is preserved the higher the disturbance  
on its functional effect. This method of scoring  
is more sensitive than the previous version  
of subPSEP scoring. All the nsSNPs predicted  
as damaging by SIFT is also predicted to be  
―probably damaging‖ by PANTHER (Table 3).  
Also, two nsSNPs predicted as tolerant are also 
predicted to be probably damaging; rs111883853 and 
rs115030945. 
 
Prediction of stability changes due to nsSNPs on FSHR 
I-Mutant uses a neural network based algorithm  
for the analysis of protein stability alterations by 
taking into account the single-site mutations.  
I-Mutant also assigns the alterations with scores  
for free energy alterations which may be calculated 
with the FOLD-X energy based web server.  
A precision of about 93% is achieved by assimilating 
the FOLD-X estimations with those of I-Mutant  
and threshold of −1.5 Kcal/mol is considered to 
predict an SNP to be destabilized. Forty six  
nsSNPs were considered as destabilized with DDG 
values by I-Mutant. Finally, we selected 13 significant 
nsSNPs because they were predicted to be deleterious 
by PROVEAN, PolyPhen, and SIFT programs and 
showed decreased structural stability following 
analysis by I-Mutant (Table 2).  
 
Effect of nsSNP variants on post translation modifications 
Various in silico tools were used to study how 
nsSNP bring about changes in the protein structure 
and interaction due to post-translation modifications. 
NetGlycan predicted that 5 residues undergo 
Table 2 — I Mutant table showing the stability changes due to 
polymorphisms 
Pos WT NEW Stability RI pH T 
680 S N Decrease 8 7.0 25 
573 R C Decrease 4 7.0 25 
567 D N Decrease 7 7.0 25 
545 I T Decrease 5 7.0 25 
519 P T Decrease 2 7.0 25 
449 T I Decrease 7 7.0 25 
419 A T Decrease 9 7.0 25 
307 A T Decrease 2 7.0 25 
189 A V Increase 6 7.0 25 
162 R K Decrease 8 7.0 25 
160 I T Decrease 7 7.0 25 
128 S Y Decrease 7 7.0 25 
8 L F Decrease 1 7.0 25 
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glycation and the position 680 which is a site of 
glycation was predicted to be benign by Polyphen 2 
software. According to NetPhos 13 serine, 6 threonine 
and 7 tyrosine residues undergo phosphorylation 
(Table 3). Protein sequence with the mutational 
position associated with nsSNPs was incorporated 
into the amino acid residue were submitted as input to 
UbPerd, 2 residue positions in the sequence had a 
score above 0, and these sites are predicted to have 
possible chances of ubiquitination in a mutated 
protein structure. Similarly, SUMOplot predicted  
4 different positions with likely chances for 
sumoylation (Table 3). FTsite evaluated and gave  
3 different ligand binding sites of FSHR gene  
(Table 3). None of the genomic variants predicted to 
be deleterious /damaging was found to be present on 
ligand binding sites; this may be due to the fact that 
the complete protein structure has not yet been 
elucidated.  
 
Protein-Protein interactions 
The protein interaction analysis carried out by 
STRING v10 showed that FSHR closely interacts with 
FSHB (Follicle stimulating hormone, beta polypeptide), 
PTH (Parathyroid hormone), BRD2 (Bromodomain 
containing 2), POMC (Proopiomelanocortin), MC2R 
(Melanocortin 2 receptor), TSHB (Thyroid stimulating 
hormone, beta), CGA (Glycoprotein hormones), 
INSL3 (Insulin-like 3 (Leydig cell)), ADRB2 
(Adrenoceptor beta 2), LHB (Luteinizing hormone 
beta polypeptide). By exploring the KEGG database, 
it was known that the FSHR protein is involved in  
the cAMP signalling pathway, neuroactive ligand-
receptor interaction pathway and ovarian steroidogenesis 
(Suppl. Fig. 1).  
 
Discussion 
Follicle Stimulating Hormone and its Receptor 
(FSHR) play very important roles in women‘s 
reproductive life
2
. FSHR inactivating mutations  
may cause infertility, primary or secondary 
amenorrhea and premature ovarian failure (POF), 
whereas activating mutations may induce ovarian 
hyperstimulation syndrome (OHSS) as an effect of 
exogenous FSH administration, or due to a 
spontaneous onset. 
‗Activating mutations‘ either make FSHR  
respond non-specifically to some tropic hormones 
(e.g., TSH) or makes it highly responsive to  
FSH, making it dynamic even in the absence  
of the ligand. ‗Inactivating mutations‘ relegate  
the receptor‘s function by either disrupting FSH 
signal transduction or altering the formation of the 
receptor-ligand complex. 
The FSHR gene was mapped on the chromosome 
number 2p21 in human
24
. The FSHR gene is 54 kb in 
size and encompasses ten exons and nine introns
25
. 
Table 3 — Post Translation modification sites 
Glycation  Serine  Tyrosine  Threonine  Ubiquitation  Sumoylation 
Position Score Pos Score Pos Score Pos Score Residue Score Pos. Score 
191 0.6417 78 0.598 110 0.921 56 0.564 294 0.62 K598 0.8 
199 0.6664 164 0.977 303 0.936 249 0.584 349 0.67 K349 0.61 
293 0.5389 232 0.893 322 0.754 329 0.582   K74 0.5 
318 0.5736 248 0.996 330 0.552 331 0.633     
680 0.4242 273 0.597 335 0.825 555 0.743     
  312 0.542 429 0.915 658 0.896     
  313 0.972 684 0.721       
  321 0.946         
  347 0.846         
  427 0.661         
  564 0.996         
  566 0.986         
  660 0.772         
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The extracellular domain (ECD) is encoded by all 
the nine exons and a part of exon 10. Exon 10 is 
huge, encodes the transmembrane domain (TMD), 
and the intracellular domain (ICD) of the receptor 
apart from the ECD. This C-terminal part of the 
ECD is known as the hinge region and is responsible 
for the signal specificity
26
. The TMD is made up of 
seven  -helices which are spaced out and 
interconnected through three extracellular (ELs)  
and three intracellular loops (ILs). The ICD  
is predominantly coupled to a G protein that  
is responsible for initiating a cascade of intracellular 
events leading to specific biological effects of the 
ligand
21
. 
The ECD is a large hydrophilic domain with  
349 amino acids and consists of the Leucine-rich 
repeat which is responsible for protein-protein 
interactions. Here, as predicted by the tools, the 
mutation at amino acid (a.a.) position 189 
(Ala189Val, exon 7) completely abolished the  
FSH - stimulated cAMP production by granulosa 
cells
27
. The (a.a.) at position 191 is a highly conserved 
glycosylation site. The mutation at position 160  
where isoleucine is changed to threonine leads  
to a condition where the primary follicles do not 
mature. The follicles developed normally up to  
the small antral stage and showed a disruption at  
the further stage this may be due to altered  
surface targeting
28
.  
The transmembrane domain, a highly conserved 
region of FSHR is composed of 264 (a.a). It is 
characterized by seven hydrophobic motifs of 20-25 a.a. 
forming transmembrane  helices connecting three 
extracellular and three intracytoplasmic loops of  
10–23 (a.a). Many of the mutations in this region 
cause LH-independent, male-limited precocious 
puberty
29,30
. A heterozygous substitution Thr449Ile 
leads to Ovarian Hyper Stimulation Syndrome 
(OHSS) during pregnancy and can lead to 
complications
31
. A mutation at site 545 is predicted  
to be damaging by the in silico tools and it is to be 
noted that this site lies within a highly conserved 
stretch of amino acids (a.a. 535-a.a. 555) region 
responsible for the production of cAMP and 
estradiol
23
. Another heterozygous mutation 
Arg573Cys failed to show maturing follicles or 
corpus leuteum in the ovary
24,32
.  
Besides these mutations, FSHR gene 
polymorphisms at specific sites - 307 and 680 alter 
the ligand binding capacity to FSH and alter the 
response. The polymorphisms may persuade the 
FSHR protein responsiveness to exogenous FSH also, 
and finally, alter the effectiveness of in vitro 
fertilization (IVF) treatment in addition to the 
probability of developing a severe OHSS due to 
superovulation. Moreover, specific sites of the  
FSHR gene may show polymorphisms that influence 
FSHR protein responsiveness to exogenous FSH and 
have clinical relevance when FSH or HMG are 
administered. 
 
Conclusion 
The in silico prediction of a functional single 
nucleotide polymorphism is supportive to modern 
genetic analysis. Thus, here we have tried to analyse 
the FSHR gene and its products using computational 
biology since the resulting knowledge after an  
in silico analysis has assisted the genetic association 
study and reduced the cost of genotyping. This  
study demonstrates the first complete investigation 
that identifies the functional SNPs in FSHR  
gene using sequence- and structure-based homology 
algorithms. Of the 357 nsSNPs, 9 were predicted 
deleterious by SIFT, 9 by PolyPhen, 9 by PROVEAN 
and 11 by PANTHER. The structural consequences  
of S143P, G258V, and Y414D variants on FSHR  
are defined in the form of solvent accessibility, 
electrostatic interaction, energy calculation, and 
multiple alignment conservation. Altered FSHR 
function due to genetic variations and mRNA 
expression may possibly play an important role  
in ascertaining susceptibility to complex disorders. 
Furthermore, protein-protein interaction pathway 
helps us to understand its interaction with  
other proteins and thus its biological function.  
Finally, the thus predicted nsSNPs will not only  
help in deriving genotype-phenotype relations but  
to certain level give information about the molecular 
basis for diverse inter-individual response to  
certain drugs. 
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